Trial · NCT02918019
Results by group50
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 50
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Absolute Change in Pre-Bronchodilator Forced Expiratory Volume in 1 Second (FEV1) | Placebo | 107 | 95% Confidence Interval 47 | Milliliters (mL) | |
| Absolute Change in Pre-Bronchodilator Forced Expiratory Volume in 1 Second (FEV1) | Astegolimab (MSTT1041A) 70mg | 130 | 95% Confidence Interval 70 | Milliliters (mL) | |
| Absolute Change in Pre-Bronchodilator Forced Expiratory Volume in 1 Second (FEV1) | Astegolimab (MSTT1041A) 210mg | 154 | 95% Confidence Interval 93 | Milliliters (mL) | |
| Absolute Change in Pre-Bronchodilator Forced Expiratory Volume in 1 Second (FEV1) | Astegolimab (MSTT1041A) 490mg | 172 | 95% Confidence Interval 110 | Milliliters (mL) | |
| Time to First Asthma Exacerbation | Placebo | NA | 95% Confidence Interval 46.6 to NA | Weeks | |
| Time to First Asthma Exacerbation | Astegolimab (MSTT1041A) 70mg | NA | 95% Confidence Interval NA to NA | Weeks | |
| Time to First Asthma Exacerbation | Astegolimab (MSTT1041A) 210mg | NA | 95% Confidence Interval NA to NA | Weeks | |
| Time to First Asthma Exacerbation | Astegolimab (MSTT1041A) 490mg | NA | 95% Confidence Interval NA to NA | Weeks | |
| Achievement in Improvement in Standardized Asthma Quality-of-Life Questionnaire (AQLQ(S)) Score | Placebo | Week 54 - Responder | 55.3 | Percentage | |
| Achievement in Improvement in Standardized Asthma Quality-of-Life Questionnaire (AQLQ(S)) Score | Astegolimab (MSTT1041A) 70mg | Week 54 - Responder | 64.8 | Percentage | |
| Achievement in Improvement in Standardized Asthma Quality-of-Life Questionnaire (AQLQ(S)) Score | Astegolimab (MSTT1041A) 210mg | Week 54 - Responder | 61.3 | Percentage | |
| Achievement in Improvement in Standardized Asthma Quality-of-Life Questionnaire (AQLQ(S)) Score | Astegolimab (MSTT1041A) 490mg | Week 54 - Responder | 68.9 | Percentage | |
| Achievement in Improvement in Standardized Asthma Quality-of-Life Questionnaire (AQLQ(S)) Score | Placebo | Week 54 - Non-responder | 44.7 | Percentage | |
| Achievement in Improvement in Standardized Asthma Quality-of-Life Questionnaire (AQLQ(S)) Score | Astegolimab (MSTT1041A) 70mg | Week 54 - Non-responder | 35.2 | Percentage | |
| Achievement in Improvement in Standardized Asthma Quality-of-Life Questionnaire (AQLQ(S)) Score | Astegolimab (MSTT1041A) 210mg | Week 54 - Non-responder | 38.7 | Percentage | |
| Achievement in Improvement in Standardized Asthma Quality-of-Life Questionnaire (AQLQ(S)) Score | Astegolimab (MSTT1041A) 490mg | Week 54 - Non-responder | 31.1 | Percentage | |
| Absolute Change in Patient-Reported Use of Short-Acting Rescue Therapy | Placebo | 0 | 95% Confidence Interval 0 to 0 | Usage | |
| Absolute Change in Patient-Reported Use of Short-Acting Rescue Therapy | Astegolimab (MSTT1041A) 70mg | 0 | 95% Confidence Interval 0 to 0 | Usage | |
| Absolute Change in Patient-Reported Use of Short-Acting Rescue Therapy | Astegolimab (MSTT1041A) 210mg | 0 | 95% Confidence Interval 0 to 0 | Usage | |
| Absolute Change in Patient-Reported Use of Short-Acting Rescue Therapy | Astegolimab (MSTT1041A) 490mg | 0 | 95% Confidence Interval 0 to 0 | Usage |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02918019/results